Posts

Showing posts with the label pharma finance

brand finance chinese pharma 2023 full report

Image
  Overall consumer perceptions of Chinese pharma brands remain positive, with good perceptions of quality and consumer care over profits, according to the Brand Finance Chinese Pharma report, which analyses and ranks the top 15 most valuable and strongest Chinese pharma brands. Popularity, consumer-centricity, product range and value are top drivers while availability is central to driving consideration for Chinese pharma brands. In addition, Chinese pharma brands are perceived being as more accessible but perceptions of community support and scientific credentials have declined.